Preparation and biological evaluation of 99mTc-TMPP as a novel agent for tumor diagnosis | ||||
| Zagazig Journal of Pharmaceutical Sciences | ||||
| Article 2, Volume 24, Issue 2, 2015, Page 65-74 PDF (619.75 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/zjps.2015.38161 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
L.M. Abdel-Aziz  1; M.F. El-Sabagh2; M.A. Motaleb2
| ||||
| 1Medicinal Chemistry, Faculty of Pharmacy- Zagazig University, Zagazig, Egypt | ||||
| 2Labeled Compound Department, Hot Lab. Center, Atomic Energy Authority, Cairo, Egypt | ||||
| Abstract | ||||
| Compound 5, 10, 15, 20 tetrakis {4-methoxyphenyl} 21H, 23H porphyrin (TMPP) was labeled with technetium-99m via direct labeling technique using stannous chloride as a reducing agent. The optimum conditions that gave high labeling yield (95.2%) of 99mTc-TMPP complex were achieved by using 3mg TMPP, 100μg SnCl2.2H2O, at pH 3 and 30min reaction time. Molecular geometry was used to illustrate the structure of complex which is formed between 99mTc and TMPP. The preclinical evaluation and biodistribution in solid tumor bearing mice showed high biological accumulation in solid tumor cells (22.66 % injected activity/ g tissue) and high T/NT ratio equal to 3.21 ± 0.15 at 30 minutes post-injection. Data described before could recommend 99mTc-TMPP as a potential targeting radiopharmaceutical for tumor imaging. | ||||
| Keywords | ||||
| Technetium-99m / TMPP / Labeling / Biodistribution /Imaging/Molecular geometry | ||||
|
Statistics Article View: 126 PDF Download: 221 |
||||
